| Date Filed | Type | Description |
| 10/12/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/04/2023 |
4
| Guy Wendy (Chief Administrative Officer) has filed a Form 4 on Processa Pharmaceuticals, Inc.|
Txns:
| Granted 10,851 restricted stock units
@ $0
Granted 55,107 restricted stock units
@ $0
Granted 40,690 restricted stock units
@ $0 |
|
| 10/03/2022 |
4
| Guy Wendy (Chief Administrative Officer) has filed a Form 4 on Processa Pharmaceuticals, Inc.|
Txns:
| Granted 10,850 restricted stock units
@ $0 |
|
| 08/09/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/05/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/11/2022 |
4
| Guy Wendy (Chief Administrative Officer) has filed a Form 4 on Processa Pharmaceuticals, Inc.|
Txns:
| Granted 247,841 restricted stock units
@ $0 |
|
| 04/04/2022 |
4
| Guy Wendy (Chief Administrative Officer) has filed a Form 4 on Processa Pharmaceuticals, Inc.|
Txns:
| Granted 4,286 restricted stock units
@ $0
Granted 10,715 restricted stock units
@ $0 |
|
| 01/06/2022 |
4/A
| Guy Wendy (Chief Administrative Officer) has filed a Form 4 on Processa Pharmaceuticals, Inc.|
Txns:
| Granted 6,722 restricted stock units
@ $0 |
|
| 01/06/2022 |
4/A
| Guy Wendy (Chief Administrative Officer) has filed a Form 4 on Processa Pharmaceuticals, Inc.|
Txns:
| Granted 6,024 restricted stock units
@ $0 |
|
| 01/04/2022 |
4
| Guy Wendy (Chief Administrative Officer) has filed a Form 4 on Processa Pharmaceuticals, Inc.|
Txns:
| Granted 6,722 restricted stock units
@ $0 |
|
| 10/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/09/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/09/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/10/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/02/2020 |
3
| Guy Wendy (Chief Administrative Officer) has filed a Form 3 on Processa Pharmaceuticals, Inc. |